logo
Fluvoxamine gains approval for obsessive-compulsive disorder
FDA delays proposal on patient drug information
Tighter safety controls needed over clinical trials, says FDA
FDA set to expand pediatric information in drug product labeling
Valproate and carbamazepine join lithium as primary treatments for bipolar disorder
Extra care urged in use of sumatriptan
The cost of complying with OSHA's bloodborne pathogens regulations
Role of beta-adrenergic-receptor antagonists with intrinsic sympathomimetic activity
Needed
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Understanding and preventing drug misadventures
Thrombocytopenia associated with diclofenac therapy
Colored deposit left in endotracheal tubes by ipratropium bromide
Ganciclovir for intravitreal injection
Case presentations and staff development
Gene therapy for treating HIV infection may be an option
Realities of the fluoxetine-to-sertraline switch
Realities of the fluoxetine-to-sertraline switch
Realities of the fluoxetine-to-sertraline switch
The Common Bond
Review and Assessment of Automated Dispensing Technologies for Inpatient Pharmacy and Nursing
Drug misadventures and pharmaceutical care